Truth is, more is not necessarily better
Coverage for weight loss is a different story: only 13 states cover obesity-indicated GLP-1s as of January 2026, and that number has been shrinking as states face budget pressure
To navigate this evolving landscape, employers should consider these actions: Engage with PBMs to clarify the formulary placement of oral Wegovy and understand how net pricing compares to the injectable version
They handle short room-temperature periods during shipping, keep well in the fridge, and stay stable longest frozen at -20C or colder
Weight loss of 710% significantly improves hepatic steatosis and inflammation, making these agents valuable tools
However, the limited bioavailability of glutathione due to rapid degradation hinders its delivery to the lens